Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesMRIEx-NFL QB Matt Hasselback points brain imaging studyThe trial’s main goal it to establish methods for diagnosing chronic traumatic encephalopathy (CTE) in the living, rather that by postmortem exams.Nuclear MedicineTelix inks deal to acquire ITM for $1.65BUltrasoundConnectivity, wellness, education at center of SDMS annual meetingUltrasoundBetter risk scoring could predict cirrhosis, HCC in patients with SLDSponsor ContentFree Webinar: CT Contrast Injection Reimagined